Executive Summary
This $2.76B batch of 30 high-value federal grants (> $5M) delivers overwhelmingly bullish signals (23/30) for IT consulting, engineering, and space firms, with top awards exceeding $100M to Accenture, Deloitte, Booz Allen, and General Dynamics from IRS, CMS, and NASA. Multi-year contracts (many to 2026-2030+) offer revenue visibility averaging $92M per award, bolstered by $1.3B+ in outlays to date and $2B+ in unexercised options for upside. Neutral signals (7/30) concentrate on non-profits/universities with cost-no-fee structures, muting equity impacts amid firm-fixed-price risks on newer awards.
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from December 25, 2025.
Investment Signals(4)
- Consulting giants dominate CMS/IRS IT awards(HIGH)▲
Accenture ($117M IRS), Deloitte ($116M CMS), and General Dynamics (2x $105-112M CMS) secure >$500M total in program integrity/IT ops, with 50-60% outlays signaling execution.
- NASA long-term space contracts surge(HIGH)▲
BAE ($104M obligation, $550M ceiling), Northrop ($102M TESS), Syncom/Jacobs ($109M), and others total >$500M with horizons to 2050, 65%+ outlays on some.
- DOL Job Corps ops lock in multi-year revenue(MEDIUM)▲
Management & Training ($100M), Serrato ($94M), Odle ($80M) win full/open comp awards through 2026-2027, 70-80% outlays indicate steady cash flow.
- BARDA biotech R&D funding validates pipelines(HIGH)▲
Modex ($104M COVID/flu antibodies), Cepheid/Danaher ($75M diagnostics) highlight pandemic prep spend to 2030, with $45M+ outlays.
Risk Flags(4)
- Execution[HIGH RISK]▼
Zero outlays on 6 new/recent awards totaling $550M+ (e.g., Accenture IRS, Southern Ohio DOE) signal funding delays.
- Execution[MEDIUM RISK]▼
Firm-fixed-price on 40%+ of awards (e.g., AWS $93M, Serrato $94M) exposes to cost overruns over 4-5 year terms.
- Execution[MEDIUM RISK]▼
Subawards average 10-40% of value (e.g., Syncom $21M/70 subs, GDIT $60M/7 subs) create dependency chains.
- Market[HIGH RISK]▼
Long horizons to 2030-2050 (8 awards) vulnerable to budget shifts in HHS/NASA.
Opportunities(3)
- ◆
$2B+ unexercised options (e.g., Southern Ohio $2.5B ceiling, Four Points $642M NASA cloud, BAE $550M) across 25+ awards.
- ◆
CMS integrity modeling repeat wins (Deloitte/GD $330M+) position for follow-ons in healthcare fraud prevention.
- ◆
Small/mid-tier firms (e.g., Project Enhancement $105M DOE, EA Engineering $68M EPA) punch above via full/open comp.
Sector Themes(4)
- ◆
12 awards >$70M (AWS, Four Points, Leidos, GDIT) target CMS/IRS/USCIS systems, with $642M+ ceilings.
- ◆
8 contracts total $700M+ to 2050 (BAE GEOXO, Northrop TESS, universities), cost-plus structures.
- ◆
7 awards $700M+ (BARDA biotech, CMS modeling, St Jude influenza) through 2029-2030.
- ◆
Cleanup ($101M Portsmouth), Job Corps ops (3x $80-100M) signal infra/human capital spend to 2031.
Watch List(4)
- 👁
{"entity"=>"Southern Ohio Cleanup LLC", "reason"=>"$101M obligated but $2.5B ceiling on DOE D&D task order 3 to 2031.", "trigger"=>"Initial outlays or option pulls >$500M"}
- 👁
{"entity"=>"Four Points Technology LLC", "reason"=>"$90M NASA cloud obligation, $642M ceiling to 2029 as SDVOSB set-aside.", "trigger"=>"Outlays exceed 70% of obligation"}
- 👁
{"entity"=>"BAE Systems Space & Mission", "reason"=>"$104M NASA GEOXO to 2050 with $450M+ options.", "trigger"=>"FY2026 funding milestone"}
- 👁
{"entity"=>"General Dynamics IT (CMS cluster)", "reason"=>"3x awards total $290M+ in health IT/fraud prevention.", "trigger"=>"Combined extensions beyond 2026"}
Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 30 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC